FTSE All-Share
4.986,34
PKT
-9,01
PKT
-0,18
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.08.20 | Lloyds Banking Group overweight | Barclays Capital | |
| 03.08.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 01.08.20 | BT Group buy | Goldman Sachs Group Inc. | |
| 31.07.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 31.07.20 | Shell (ex Royal Dutch Shell) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.07.20 | BAT Sector Perform | RBC Capital Markets | |
| 31.07.20 | BAT buy | Goldman Sachs Group Inc. | |
| 31.07.20 | GSK buy | Goldman Sachs Group Inc. | |
| 31.07.20 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 31.07.20 | BAT overweight | JP Morgan Chase & Co. | |
| 31.07.20 | Lloyds Banking Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.07.20 | Lloyds Banking Group Neutral | JP Morgan Chase & Co. | |
| 30.07.20 | Shell (ex Royal Dutch Shell) Neutral | JP Morgan Chase & Co. | |
| 30.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 30.07.20 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 30.07.20 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.07.20 | Lloyds Banking Group Outperform | RBC Capital Markets | |
| 30.07.20 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
| 30.07.20 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 30.07.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.07.20 | Rio Tinto buy | Deutsche Bank AG | |
| 30.07.20 | GSK Neutral | Credit Suisse Group | |
| 30.07.20 | Barclays Neutral | Credit Suisse Group | |
| 30.07.20 | Barclays buy | Deutsche Bank AG | |
| 30.07.20 | Rio Tinto Neutral | UBS AG | |
| 30.07.20 | Barclays buy | UBS AG | |
| 30.07.20 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 29.07.20 | GSK Neutral | JP Morgan Chase & Co. | |
| 29.07.20 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 29.07.20 | Rio Tinto Neutral | Goldman Sachs Group Inc. | |
| 29.07.20 | AstraZeneca overweight | Barclays Capital | |
| 29.07.20 | Barclays Sector Perform | RBC Capital Markets | |
| 29.07.20 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 29.07.20 | Barclays buy | Jefferies & Company Inc. | |
| 29.07.20 | Barclays overweight | JP Morgan Chase & Co. | |
| 28.07.20 | BP Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.07.20 | BT Group Equal weight | Barclays Capital | |
| 28.07.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 28.07.20 | BP overweight | JP Morgan Chase & Co. | |
| 28.07.20 | AstraZeneca overweight | JP Morgan Chase & Co. |